Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proellex for Symptomatic Endometriosis
NCT01728454Phase 2Completed
- Sponsor
- Repros Therapeutics Inc.
- Start
- May 2013
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of telapristone in endometriosis, sponsored by Repros Therapeutics Inc.. Started May 2013; status: completed.
02
Drugs
telapristone
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01728454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01728454.